Therapeutic Goods Administration Performance Report - 2022-23

About the report

Each year we provide information about our regulatory performance through the TGA Performance Report. We measure our performance in line with Commonwealth best practice principles, as a platform for the strategic objectives and focus areas outlined in the TGA Business Plan. The principles are as follows:

• Continuous improvement and building trust 

• Risk-based and data driven 

• Collaboration and engagement 

Using these principles as a foundation, we have measured our performance against the strategic objectives and focus areas outlined in our 2022-23 TGA Business Plan. Our strategic objectives are as follows:

1. Improve public health outcomes through regulation
2. Actively engage with our stakeholders
3. Promote compliance with regulatory requirements
4. Innovate and continuously improve

We have outlined notable activities in this report, across 41 focus areas corresponding to the four strategic objectives. Each strategic objective has several performance indicators against which we report our activities.

Due to the breadth and volume of work, it is not possible to mention all activities and achievements during the 2022-23 financial year. We regularly provide updates on our activities and achievements through various external mechanisms including our website, email newsletters, social media, events, webinars and various stakeholder forums.  

This report contains performance statistics in the appendices covering the period 1 July 2022 to 30 June 2023. These statistics are arranged into product themes and work programs and may include outcomes associated with key performance indicators and other performance targets.

Contents 

• Message from the Deputy Secretary

• Our purpose

• Our vision 

• Our strategic framework

• Introduction 

• Strategic objective 1 -  Improve public health outcomes through regulation

• Strategic objective 2 – Actively engage with our stakeholders

• Strategic objective 3 – Promote compliance with regulatory requirements

• Strategic objective 4 – Innovate and continuously improve

• Appendices